18194-24-6

18194-24-6 is a lipid of Glycerophospholipids (GP) class. 18194-24-6 is associated with abnormalities such as Cerebrovascular accident, Renal tubular disorder, Atherosclerosis, Hyperlipoproteinemia Type III and Lipid Metabolism Disorders. The involved functions are known as Process, protein folding, Catalyst, Biochemical Pathway and Fold in Medical Device Material. 18194-24-6 often locates in Tissue membrane, Membrane, periplasm, vesicle membrane and outer membrane. The associated genes with 18194-24-6 are Integral Membrane Proteins, Protein Structure, RTN4 gene, RTN4R gene and Protein, Organized by Structure. The related lipids are Micelles, dimyristoylphosphatidylglycerol, 1,2-dihexadecyl-sn-glycero-3-phosphocholine, Unilamellar Vesicles and cholesteryl oleate. The related experimental models are Mouse Model, Arthritis, Adjuvant-Induced, Disease model and Xenograft Model.

Cross Reference

Introduction

To understand associated biological information of 18194-24-6, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 18194-24-6?

18194-24-6 is suspected in Atherosclerosis, Cardiovascular Diseases, Dehydration, Abnormal shape, Renal tubular disorder, Hyperlipoproteinemia Type III and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 18194-24-6

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Adenocarcinoma D000230 166 associated lipids
Lung Neoplasms D008175 171 associated lipids
Body Weight D001835 333 associated lipids
Carcinoma D002277 18 associated lipids
Osteosarcoma D012516 50 associated lipids
Lymphoma, Large B-Cell, Diffuse D016403 13 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Alzheimer Disease D000544 76 associated lipids
Arteriosclerosis D001161 86 associated lipids
Per page 10 20 50 | Total 22

PubChem Associated disorders and diseases

What pathways are associated with 18194-24-6

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 18194-24-6?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 18194-24-6?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 18194-24-6?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 18194-24-6?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 18194-24-6?

Mouse Model

Mouse Model are used in the study 'Association of a model class A (apolipoprotein) amphipathic alpha helical peptide with lipid: high resolution NMR studies of peptide.lipid discoidal complexes.' (Mishra VK et al., 2006).

Arthritis, Adjuvant-Induced

Arthritis, Adjuvant-Induced are used in the study 'T cell antigen receptor peptide-lipid membrane interactions using surface plasmon resonance.' (Bender V et al., 2004).

Disease model

Disease model are used in the study 'Kupffer cells do not play a role in governing the efficacy of liposomal mitoxantrone used to treat a tumor model designed to assess drug delivery to liver.' (Lim HJ et al., 2000).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with 18194-24-6

Download all related citations
Per page 10 20 50 100 | Total 3218
Authors Title Published Journal PubMed Link
Mason RP et al. Molecular membrane interactions of a phospholipid metabolite. Implications for Alzheimer's disease pathophysiology. 1996 Ann. N. Y. Acad. Sci. pmid:8624114
Levi V et al. An improved method to measure the interactions of p-type ATPases with the lipidic environment. 2003 Ann. N. Y. Acad. Sci. pmid:12763823
Jonas A et al. View from fluorescence analyses: interaction of apolipoprotein A-I with L-alpha-dimyristoylphosphatidylcholine vesicles. 1980 Ann. N. Y. Acad. Sci. pmid:6772078
van Deenen LL et al. Effects of altered phospholipid molecular species on erythrocyte membranes. 1987 Ann. N. Y. Acad. Sci. pmid:3474924
Miller AG and Gerrard JA Assessment of protein function following cross-linking by alpha-dicarbonyls. 2005 Ann. N. Y. Acad. Sci. pmid:16037239
Biaggi MH et al. Interaction of melanotropic peptides with lipid membranes. 1993 Ann. N. Y. Acad. Sci. pmid:8390168
Umebayashi M et al. Inhibitory effects of cationic hybrid liposomes on the growth of human renal cell carcinoma. 2010 Anticancer Res. pmid:20332436
Ichihara H et al. Therapeutic effects of hybrid liposomes on gastric carcinoma involve apoptosis. 2010 Anticancer Res. pmid:20651345
Ichihara H et al. Nanotherapy with hybrid liposomes for colorectal cancer along with apoptosis in vitro and in vivo. 2014 Anticancer Res. pmid:25202047
Maswadeh H et al. Accumulation of vinblastine into transfersomes and liposomes in response to a transmembrane ammonium sulfate gradient and their cytotoxic/cytostatic activity in vitro. 2001 Jul-Aug Anticancer Res. pmid:11724324
Clark JM et al. Amphotericin B lipid complex therapy of experimental fungal infections in mice. 1991 Antimicrob. Agents Chemother. pmid:2069367
Clemons KV and Stevens DA Comparative efficacies of amphotericin B lipid complex and amphotericin B deoxycholate suspension against murine blastomycosis. 1991 Antimicrob. Agents Chemother. pmid:1759840
Joly V et al. Influence of phospholipid/amphotericin B ratio and phospholipid type on in vitro renal cell toxicities and fungicidal activities of lipid-associated amphotericin B formulations. 1992 Antimicrob. Agents Chemother. pmid:1605590
Swenson CE et al. In vitro and in vivo antifungal activity of amphotericin B lipid complex: are phospholipases important? 1998 Antimicrob. Agents Chemother. pmid:9559780
Wasan KM et al. Roles of liposome composition and temperature in distribution of amphotericin B in serum lipoproteins. 1993 Antimicrob. Agents Chemother. pmid:8452354
Sigalov AB and Stern LJ Dihydrolipoic acid as an effective cofactor for peptide methionine sulfoxide reductase in enzymatic repair of oxidative damage to both lipid-free and lipid-bound apolipoprotein a-I. 2002 Antioxid. Redox Signal. pmid:12215223
Aygun A et al. Investigation of factors affecting controlled release from photosensitive DMPC and DSPC liposomes. 2012 Appl. Biochem. Biotechnol. pmid:22592778
Yadav MK et al. Phospholipid/Polydiacetylene Vesicle-Based Colorimetric Assay for High-Throughput Screening of Bacteriocins and Halocins. 2017 Appl. Biochem. Biotechnol. pmid:27844338
Gaussier H et al. Binding of pediocin PA-1 with anionic lipid induces model membrane destabilization. 2003 Appl. Environ. Microbiol. pmid:14602640
Yin JJ et al. Effects of fumonisin B1 and (hydrolyzed) fumonisin backbone AP1 on membranes: a spin-label study. 1996 Arch. Biochem. Biophys. pmid:8914830